SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Journal of Neuro-Oncology – Diffuse midline gliomas (DMG) include all midline gliomas with a point mutation to the histone H3 gene resulting in the substitution…
The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
In acute myeloid leukemia, investigators are exploring novel agents engineered to target adhesion factors, which can mobilize persistent leukemic stem cells from the bone marrow…
Brian Slomovitz, MD, details findings from the innovaTV 301 trial investigating tisotumab vedotin for the treatment of recurrent or metastatic cervical cancer.
An abstract is unavailable.
Get the latest on mammogram guidelines from Dr. Ethan Cohen at MD Anderson Cancer Center, as he breaks down the updates and shares his expert…
AHNS Annual Meeting at Combined Otolaryngology Spring Meetings (COSM) 2024 Join all 9 Societies in Chicago, IL! REGISTRATION IS NOW OPEN! Register for the AHNS…
Fred Hutch providers weigh in on new guidelines just issued by the U.S. Preventive Services Task Force that recommend breast cancer screening start at age…
Oncologists present the clinical scenario of a 65-year-old woman with recurrent HR-positive, HER2-low breast cancer, and discuss optimal sequencing of systemic therapies in this setting.
Cervical cancer screening exams like the Pap test and screening for the human papillomavirus (HPV) help find cervical cancer early stage. When found early, the…